Your browser doesn't support javascript.
loading
Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients.
Ruggeri, Enzo Maria; Nelli, Fabrizio; Giannarelli, Diana; Fabbri, Agnese; Giron Berrios, Julio Rodrigo; Virtuoso, Antonella; Marrucci, Eleonora; Mazzotta, Marco; Schirripa, Marta; Signorelli, Carlo; Chilelli, Mario Giovanni; Primi, Francesca; Fiore, Cristina; Panichi, Valentina; Topini, Giuseppe; Silvestri, Maria Assunta.
Affiliation
  • Ruggeri EM; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy. enzo.ruggeri@asl.vt.it.
  • Nelli F; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy.
  • Giannarelli D; Biostatistics Unit, Scientific Directorate, IRCCS, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.
  • Fabbri A; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy.
  • Giron Berrios JR; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy.
  • Virtuoso A; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy.
  • Marrucci E; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy.
  • Mazzotta M; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy.
  • Schirripa M; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy.
  • Signorelli C; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy.
  • Chilelli MG; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy.
  • Primi F; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy.
  • Fiore C; Medical Oncology Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Strada Sammartinese Snc, 01100, Viterbo, Italy.
  • Panichi V; Cytofluorimetry Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Viterbo, Italy.
  • Topini G; Cytofluorimetry Unit, Department of Oncology and Hematology, Central Hospital of Belcolle, Viterbo, Italy.
  • Silvestri MA; Department of Oncology and Hematology, Microbiology and Virology Unit, Central Hospital of Belcolle, Viterbo, Italy.
Sci Rep ; 12(1): 21908, 2022 12 19.
Article in En | MEDLINE | ID: mdl-36535985
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine / Antibody Formation / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine / Antibody Formation / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Year: 2022 Type: Article